The antiapoptotic protein B‐cell lymphoma‐2 (BCL‐2) has been a focus of intensive research efforts [22], as changes in BCL‐2 expression levels can contribute to improperly regulated apoptotic activity and aberrant cell proliferation conducive to oncogenesis and tumor progression [23]. The gene discussed is BCL2; the disease is neoplasm.